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Abstract 
 
This research work is focused on the preparation of macroporous glass-ceramic scaffolds with high 
mechanical strength, equivalent with cancellous bone. The scaffolds were prepared using an open-
cells polyurethane sponge as a template and glass powders belonging to the system SiO2-P2O5-CaO-
MgO-Na2O-K2O. The glass, named as CEL2, was synthesized by a conventional melting-quenching 
route, ground and sieved to obtain powders of specific size. A slurry of CEL2 powders, polyvinyl 
alcohol (PVA) as a binder and water was prepared in order to coat, by a process of impregnation, 
the polymeric template. A thermal treatment was then used to remove the sponge and to sinter the 
glass powders, in order to obtain a replica of the template structure. The scaffolds were 
characterized by means of X-ray diffraction analysis, morphological observations, density 
measurements, volumetric shrinkage, image analysis, capillarity tests, mechanical tests and in vitro 
bioactivity evaluation. 
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1 Introduction 
 
Since the birth of orthopaedic surgery, bone losses were traditionally replaced by using materials 
coming from the patient body (autograft) or from an external donor (allograft). Autografts are 
generally considered the more effective solution for bone replacing and substitution, but the bone 
volume that can be safely drawn is limited and problems of pain or morbidity in the harvest site can 
occur for the patient [1]. The use of allografts, although stored in proper bone banks, could involve 
the risk of pathogen diseases transfer from the donor to the patient and besides their quality can be 
not always satisfactory [2]. Thus, an increasing interest has been turned to synthetic materials, that 
overcome antigenicity and morbidity problems, are available without amount limitations and can be 
easily processed to obtain scaffolds [3]. Bioceramics have been widely investigated as bone graft 
materials for many decades, and have a range of applications including bone defects filling [4], 
fracture fixation [5], trauma [6], tumors [7], maxillofacial [8] and spinal surgery [9], drug delivery 
systems [10]. Among the glass and ceramic materials, calcium and phosphate salts [11], calcium 
sulfate [5], hydroxyapatite (HAp) [12], bioactive glasses and glass-ceramics [13,14] are usually 
used for scaffolds preparation. 
An effective scaffold for bone tissue engineering should promote bone regeneration. At this 
purpose, a network of open and highly interconnected macropores in the 100-500 m range is 
required in order to allow the vascularization of the scaffold [15]. 
Microporosity is another important feature because it favours proteins adhesion and thus cells 
attachment on the scaffold and allows the flow of nutrients to reach the cells within the scaffold 
[16]. The scaffold roughness is also a crucial point for the implant success, because it is known that 
a rough surface stimulates osteoblasts adhesion and proliferation [17]. 
A good balance between a high degree of porosity and mechanical properties comparable with 
cancellous bone (2-12 MPa) must be pursued [18]. Previous investigations demonstrated that it is 
not easy to reach this compromise: in many studies ceramic scaffolds with a very good degree of 
porosity (above 50 %vol. is usually required) but unsatisfactory mechanical properties (below 1 
MPa) were produced [19,20]. A scaffold for bone substitution should be bioactive, i.e. the implant 
is not only osteoinductive, but also induces osteoproduction [21,22]. Bioactive scaffolds can favour 
the apposition of new bone on their surfaces through a complex mechanism of ion exchange with 
body fluids and stimulate the differentiation and maturation of mesenchimal stem cells into 
osteoblasts [23].  
Glass and glass-ceramic scaffolds can be prepared by using different methods; for instance, 
freeform fabrication techniques [24], sponge replication [25,26], starch consolidation [27] and 
polymeric particles burning-out [28]. 
The sponge replication method was chosen for the present work. A commercial polyurethane 
sponge, possessing an open and interconnected structure, was used as a template for a ceramic 
replica through its impregnation with a slurry of glass powders followed by a thermal treatment. 
This work is focused on the preparation and characterizations of glass-ceramic bioactive scaffolds 
with trabecular texture and mechanical properties analogous to cancellous bone. Specifically, the 
aim of this research concerns the optimisation of the scaffold mechanical properties in order to 
improve the results obtained in a previous work, in which scaffolds possessing a mechanical 
strength of 1.0 ± 0.4 MPa were described [25]. The main effort was spent in order to set up a 
processing schedule able to lead to a bioactive glass-ceramic scaffold with tailored porosity, 
according to the above mentioned requirement for a bone scaffold, without compositional 
modifications of the glass. 
 
2 Experimental procedure 
 
2.1 Materials 
 
In this research work, glass-ceramic macroporous scaffolds were prepared using a polyurethane 
sponge as organic template and bioactive glass-ceramic powders. 
The chosen glass-ceramic, hereafter named as CEL2 [29], belongs to the system SiO2-P2O5-CaO-
MgO-Na2O-K2O and has the following molar composition: 45% SiO2, 3% P2O5, 26% CaO, 7% 
MgO, 15% Na2O, 4% K2O. 
Briefly, CEL2 was prepared by melting the raw products (SiO2, Ca3(PO4)2, CaCO3, 
4MgCO3Mg(OH)2·5H2O, Na2CO3, K2CO3) in a platinum crucible at 1400 °C for 1 h in air and by 
then quenching the melt in cold water to obtain a frit, that was subsequently ground by ball milling 
and sieved to a final grain size below 30 μm. The glass CEL2 was thermally characterized in a 
previous work [29] and showed a glass transition temperature Tg at 550 °C and two crystallization 
temperature TX1 at 600 °C and TX2 at 800 °C. 
 
2.2 Scaffolds preparation 
 
The chosen organic template is a commercial polyurethane sponge with an open and interconnected 
macroporosity. The sponge was cut into 1.5 cm × 1.5 cm × 1.5 cm cubic blocks, and then 
impregnated with a water-based CEL2 slurry.  
CEL2 slurry was prepared by dispersing the glass powders into distilled water with polyvinyl 
alcohol (PVA) used as binder in order to control the slurry viscosity and to optimise the ability of 
glass particles to uniformly coat the sponge. The weight ratio of the slurry components was: 30% 
CEL2, 6% PVA, 64% water (final solid load 30% wt.). First PVA was hydrolyzed and stirred in 
distilled water at a temperature of 60 °C for 1 h, and then CEL2 powders were dispersed in the 
solution. The water evaporated during PVA dissolution was re-added in order to obtain the chosen 
solid load. Then the porous sponge underwent the impregnation process. The sponge blocks were 
soaked into the glass slurry for 60 s and taken back for several times, followed by cycles of 
compression to reduce the sponge in thickness along the three spatial directions, in order to remove 
the exceeding slurry. In particular, the sponge blocks underwent a pressure of 20 kPa for 1 s.  
In this work, different impregnation processes, labelled as method A, B and C, were carried out in 
order to optimise the mechanical strength of the scaffolds through a better covering of the 
polymeric template. 
The features of the three methods can be resumed as it follows: 
- method A: the sponge blocks were soaked in the CEL2 slurry and shrunk up to 60% in 
thickness along the three spatial directions; these impregnation/compression cycles were 
repeated for three times. After each cycle the impregnated sponge was left 60 s in air to 
restore and de-compress. 
- method B: the sponge blocks were soaked in the CEL2 slurry and shrunk up to 60% in 
thickness along the three spatial directions; this infiltration/compression cycle was repeated 
for three times. A further cycle in which the sponge was shrunk only up to 33% in thickness, 
was added. Also in this case the cycles are spaced by 60 s of restore. 
- method C: the sponge blocks were soaked in the CEL2 slurry and shrunk up to 60% in 
thickness along the three spatial directions; this infiltration/compression cycle was repeated 
for three times. A further cycle of impregnation without any compression was added. Also 
in this case the cycles are spaced by 60 s of restore. 
 
After the impregnation phase, the samples were dried at room temperature for 3 h and then 
introduced into the furnace at room temperature. The thermal treatment was performed at 950 °C 
(method A and B) or at 1000 °C (method C) for 3 h (heating and cooling rate were 5 and 10 °C/min 
respectively) in order to remove the organic phase and to sinter the inorganic one, obtaining 
macroporous glass-ceramic scaffolds. 
In addition another three sub-methods of preparation, labelled from now on as A-1, B-1 and B-2, 
were performed in order to optimise step-by-step the mechanical properties maintaining a 
satisfactory degree of porosity. The impregnation process of method A-1 was the same of method 
A, but before sintering at 950 °C for 3 h the samples underwent a two-steps drying process: thermal 
treatment at 80 °C for 2 h (heating rate 3 °C/min) in order to gradually evaporate the ethanol 
followed by a treatment at 600 °C for 2 h (heating rate 3 °C/min)  to remove the polymeric sponge 
at a constant temperature. This procedure was set in order to avoid the formation of cracks in the 
impregnated body and during the skeleton removal. 
The method B-1 involved the use, in the starting slurry, of ethylene glycol (EG) as drying chemical 
control additive (DCCA). Specifically, the weight ratio of the slurry components was modified as 
follows: 30% CEL2, 6% PVA, 10% EG, 54% water. The presence of EG, as previously reported in 
literature, should lead to the prevention of cracks formation during the drying process of the 
samples [11,30] and thus obtaining an increase of the mechanical properties. 
In the method B-2 the sponge impregnation was the same of method B, but the thermal treatment 
was set at 1000 °C for 3 h in order to investigate the influence of the degree of sintering on the final 
mechanical strength. 
Details of the methods adopted for the scaffold preparation are summarized in table 1. 
 
2.3 Scaffolds characterization 
 
X-ray diffraction (X’Pert Philips diffractometer) using the Bragg Brentano camera geometry and 
the Cu-K incident radiation, was carried out on the scaffolds reduced into powders in order to 
assess the presence of crystalline phases. The microstructure of the scaffolds was qualitatively 
studied through scanning electron microscopy (SEM Philips 525 M) in order to observe the degree 
of sintering (presence of dense sintering necks) and to evaluate the pores size, morphology, 
distribution and interconnection. 
The total pore content (% vol.) of the scaffolds was assessed through weight measurements testing 
five polished 1 cm × 1 cm × 1 cm samples, prepared according to each methods reported in table 1, 
by the following calculation: 
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where Wm is the measured weight and Wth the theoretical one calculated from the product of glass 
density and the sample volume. 
The presence of a highly interconnected pores network and a diffuse microporosity was 
qualitatively assessed through capillarity tests using bovine serum, in which some drops of red ink 
were dispersed, to simulate the colour of biological fluids. A face of the scaffold was put into 
contact with a thin film of fluid, to verify if serum was infiltrating the scaffold due to capillarity 
forces. 
In addition, a quantitative evaluation of the pores size distribution and amount was attained through 
image analysis studies (Qwin Leica software) on different scaffold cross-sections. The volumetric 
shrinkage of the impregnated sponges, due to the organic skeleton removal and to the CEL2 
softening and sintering, was evaluated by measuring five samples for each type of the prepared 
scaffolds as 1001
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Vs , where Vs is the scaffold volume and V0 is the volume of the 
impregnated sponge before the thermal treatment. 
The scaffolds were carefully polished to obtain 1 cm × 1 cm × 1 cm cubic samples used for the 
mechanical tests. The strength of the scaffolds was evaluated through destructive compressive tests 
using an Instron machine and testing 5 specimens for each preparation method. The failure stress 
was obtained dividing the maximum load registered during the test by the resistant section area; the 
cross-head speed was 1 mm/min. 
The bioactivity study was carried out in vitro by soaking the scaffolds for 1 week in a simulated 
body fluid (SBF), which has an ions concentrations analogous to human plasma [31]. Specifically, 
cubic samples were soaked in 30 ml of SBF maintained at 37 °C in polyethylene bottles; every 48 h 
a refresh of the solution was carried out to simulate fluid circulation in the human body.  
 
 3 Results and discussion 
 
Figure 1 shows the morphology of the polyurethane open-cells sponge used as a template for the 
preparation of CEL2 glass-ceramic scaffolds. The sponge has a 3-D  highly interconnected structure 
analogous to cancellous bone. Pores size ranged from 100 up to 1000 m and the thickness of the 
trabeculae is few tens of microns. The choice of CEL2 as starting material for the scaffolds was due 
to its excellent biological behaviour, as already assessed in a previous work [25]. 
The polymeric sponge can be easily cut, thus, as shown in figure 2, scaffolds of various shapes – 
cubic, prismatic, thin regular plate – can be produced. 
The impregnation process and the drying conditions of the impregnated sponge were optimised in 
order to enhance the mechanical strength of the scaffolds maintaining a satisfactory porosity degree. 
The scaffolds were obtained through a thermal treatment at 950 °C or 1000 °C for 3 h. The 
polyurethane sponge was completely removed at 600 °C, thus no contamination of the scaffolds 
was foreseen and actually assessed. 
The scaffolds were characterized by means of XRD analysis, morphological observations (SEM), in 
vitro and biological tests, volumetric shrinkage, density measurements, image analysis, capillarity 
tests and mechanical tests. 
 
3.1 XRD analysis and morphological investigations 
 
The XRD pattern on the as melt is reported in fig. 3a, whilst the diffraction pattern obtained for the 
scaffold after milling is shown in fig. 3b (950 °C for 3 h) and 3c (1000 °C for 3 h). As it can be 
observed the as-poured CEL2 is a completely amorphous glass and a broad halo was found. The 
thermal treatment carried out to produce the scaffolds induced the nucleation of two crystalline 
phases, that were identified  as combeite (Na4Ca4(Si6O18), JCPDF 01-078-1649) and akemanite 
(Ca2Mg(Si2O7), JCPDF 01-077-1149) according to the two TXX found with the thermal analysis 
[29]. No significant difference was found between the samples sintered at 950°C and 1000°C, since 
the 2 crystallization temperatures are both below the sintering temperatures.  
The results of the sponge impregnation process can be observed in figure 4, 5 and 6, referring to 
method A, B and C respectively. For what concerns method A, most of the pores are still open after 
the impregnation process (figure 4a), but the sponge trabeculae are only partially covered by the 
glass powders (figures 4b and 4c). On the contrary, method B was more effective for the sponge 
impregnation: some clotted pores can be observed in figure 5a, probably due to an incomplete slurry 
removal, but the sponge trabeculae were almost uniformly covered by CEL2 powders (figures 5b 
and 5c). Method C gives the best results, involving a complete and uniform coating of the sponge 
trabeculae with CEL2 particles (figures 6b and 6c). Some clotted pores are visible (fig. 6a), due to 
the lack of compressions after the fourth sponge impregnation (table 1). 
Figure 7 shows, as an example, the surface and the cross-section of a sintered scaffold obtained with 
method B. Some clotted pores can be observed, as already noticed in fig. 5 for the impregnated 
sponge. Figures 8 and 9 show that a high pore interconnection and a very good sintering degree of 
CEL2 particles was achieved both with method A and method B. The sintering temperature was 
increased in method B-2 from 950 up to 1000 °C in order to obtain a further improvement of 
trabeculae densification. Figure 10 shows that an excellent result was achieved, because the 
trabeculae are well densified (fig. 10a) and it was almost impossible to distinguish the original glass 
particles (fig. 10b). Similar features were achieved by adopting the method C; the resulting porous 
structure of the scaffold is showed in fig. 11. It should be noticed that the trabeculae of C-scaffold 
(fig. 11a) are thicker than the struts of B-2-scaffold (fig. 11b). The same sintering temperature 
(1000 °C) was used both for method B-2 and C, but in the latter one no sponge compressions were 
performed after the fourth impregnation cycle, thus involving a better coating of sponge structure 
by CEL2 particles.  
The structure of the polymeric sponge was substituted by a sintered scaffold with similar texture; 
the resulting trabecular structure, possessing a highly interconnected network of macropores 
ranging within 100-600 m, closely mimicking the natural cancellous bone. 
 
3.2 Porosity analysis 
 
The total porosity was assessed through weight measurement on 1 cm × 1 cm × 1 cm cubic samples, 
knowing the CEL2 true density (2.6 g/cm
3
). Table 2 reports the so calculated porosity values 
comparing the results obtained for the different preparation methods. The porosity values obtained  
for all the prepared samples are well above 50%vol. and thus completely satisfy the requirements 
for a in-growth material for bone grafting. 
The volumetric shrinkage of the samples, calculated testing 5 specimens for each method of 
scaffold production, is reported in table 3. The data are consistent with the porosity values reported 
in table 2; in fact, a higher volumetric shrinkage of the scaffold involves a decrease of the pores 
content. A low standard deviation was found for the samples shrinkage, assessing a good 
reproducibility of the adopted preparation methods. In addition, it is possible to obtain scaffolds of 
desired shape and size by carefully tailoring the size of PU sponge, as already reported in fig. 2.  
Figure 12 reports the results of capillarity tests. Specifically, fig. 12a shows the sample appearance 
immediately after the test: the fluid went up through scaffold pores network in about 2 s. In figure 
12b the cross-sections of a CEL2 scaffold after the test and of an as-done scaffold are compared. 
The presence of the serum in the inner part of the scaffold further confirms the high interconnection 
degree of the porous texture. 
Moreover, the scaffolds porosity was quantitatively investigated by means of image analysis carried 
out on scaffold cross-sections using the Qwin Program of Leica; this technique aims to assess the 
pores size distribution and the total pores amount. First, the porosity of different SEM micrographs 
is highlighted by increasing the black and white contrast; then, a measure frame is selected and the 
software elaborates the images as binary pictures identifying the dark area as pores. The equivalent 
pores diameter is evaluated as A2 , where A is the effective area calculated by the software. The 
acquired data are further processed to obtain two bar charts showing the pores amount and the pores 
area versus the pores equivalent diameter. 
An example of the analysis, referring to method B, is reported in fig. 13; analogous results were 
obtained for the scaffolds prepared with the other methods.  
All the prepared scaffolds are characterized by a bimodal porous structure, in which both 
micropores (size below 100 m) and macropores (size within 100-1000 m) can be identified. The 
presence of micropores, creating a roughness on scaffold walls, is an important feature because 
small pores promote proteins and cells adhesion in vivo [16,17]. As shown in fig. 13a, the 
contribution of the micropores was prevalent in terms of pores amount (over 80%). 
Macropores over 100 m are fundamental for a good vascularisation of the implant to allow the 
blood vessels to reach the inner part of the scaffold [15]. Figure 13b shows that the main 
contribution to the total pores area (about 80%) was given by pores within 100-1000 m. 
 
3.3 Mechanical strength tests  
 
Five samples (1 cm × 1 cm × 1 cm cubic samples) for each method of scaffold production were 
tested in compression; the results are reported in table 4. 
An example of the stress-strain curve for the CEL2 scaffold is reported in fig. 14. In particular, the 
curve has a positive slope up to a first peak; then the scaffold begins to crack in the thinner struts at 
the stress-concentrating sites, causing an apparent stress drop. This is known as “pop-in behaviour” 
and corresponds to the onset of thin trabeculae cracks propagation. Nevertheless, the scaffold was 
still able to bear higher loads, so that the stress rises again; the repetition of this behaviour gave a 
jagged stress-strain curve while the thin struts cracking occurs. When the maximum stress is 
reached, the thick struts are fractured and so the curve has a negative slope. 
The pore content was the crucial factor affecting the mechanical properties of the scaffolds. The 
total porosity (table 2), assessed via density measurements, was high for the scaffolds prepared with 
method A (68.5 ± 4.6% vol.), but the mechanical strength was low (1.6 ± 0.5 MPa) with respect to 
the spongious bone (2-12 MPa) [18]. For the scaffolds prepared with method A-1, the total pore 
amount (72.3 ± 3.3% vol.) and the mechanical strength (1.3 ± 0.4 MPa) were close to the values 
obtained with method A, thus it was possible to conclude that the drying treatment, adopted before 
the sintering process, has no significant influence for the scaffold strength.  
The scaffolds prepared with method B showed a higher mechanical strength compared to the 
scaffolds prepared with method A, due to the presence of a lower porosity in the latter ones; as 
expected, a decrease of the porosity involved an increase of the compressive strength. The strengths 
of the scaffolds obtained with methods B (3.9 ± 0.4 MPa), B-1 (3.8 ± 0.4 MPa) and B-2 (4.7 ± 0.6 
MPa) are comparable to the strength of the cancellous bone (2-12 MPa).  
No significant differences, concerning porosity and mechanical strength, were introduced by using 
the ethylene glycol (EG) in the starting slurry as DCCA slurry (method B-1) and so this additive 
was not used for methods B-2 and C. 
Instead, the increase of sintering temperature from 950 up to 1000 °C intensely influenced the 
strength of the scaffolds (method B-2) by promoting a higher densification of the struts. Therefore 
the scaffolds prepared with method C were directly sintered at 1000 °C. A further increase of the 
compressive strength (5.4 ± 1.5 MPa), consistent with a decrease of the total pore content of the 
scaffolds (53.5 ± 3.7 % vol.), was finally reached through this last method. 
A very significant improvement in the mechanical strength was attained in comparison with a 
previous work in which CEL2 scaffolds possessing a strength of 1.0 ± 0.4 MPa were prepared [25]. 
In particular, the most interesting samples are the ones produced with methods B-2 and C. The 
choice of a preparation method, that involves the features of the scaffold in terms of pores content 
and strength, is related to the specific application of the implant. For general purposes, the best 
compromise between high porosity and mechanical properties is represented by the scaffolds 
prepared with method B-2, whereas the method C can be used to fabricate scaffolds requiring 
specifically high-strength features.  
Finally, regarding the values of pores content and mechanical strength reported in tables 2 and 4 
respectively, for any series of scaffolds a very low standard deviation was observed, thus assessing 
the reproducibility of all the proposed methods. 
 
3.4 In vitro bioactivity 
 
Figure 15a shows, as an example of in vitro bioactivity tests, the surface of a scaffold after 1 week 
of soaking in SBF. As it can be observed, the scaffold struts are completely covered by globular 
hydroxyapatite (HAp) agglomerates, whose presence is also confirmed by XRD analysis reported in 
fig. 15b (JCPDF 01-082-1943). 
Besides, as previously assessed [25], CEL2 scaffolds exhibited excellent biological properties when 
tested with MG-63 cells line (American Type Culture Collection, Rockville, USA). CEL2 scaffold 
biological behaviour is illustrated, as an example, in fig. 16, where a very good colonisation of the 
scaffolds by osteoblasts can be observed both after 10 days and 20 days of incubation. The cells 
appeared strongly adherent on scaffold surface with many protrusions due to their filopodia. MG-63 
cells preferentially anchored across the HAp agglomerates (the scaffolds were pre-treated in SBF 
for 1 week), and exhibited a smooth and flatten morphology indicating that CEL2 scaffolds are an 
excellent substrate for osteoblasts attachment, spreading and proliferation. 
 
 
 
4 Conclusions 
 
In this research work, 3-D bioactive glass-ceramic scaffolds were obtained via the sponge-
impregnation method followed by a thermal treatment in order to remove the organic phase and to 
sinter the inorganic one. A polyurethane open-cells sponge was used as a template. The obtained 
scaffolds are characterized by a trabecular texture similar to the spongious bone, with open, highly 
interconnected macropores and a diffused microporosity.  
The sponge impregnation parameters and the sintering temperature were successfully optimised in 
order to obtain scaffolds with a satisfactory degree of porosity and mechanical strength comparable 
with the trabecular bone (2-12 MPa). Scaffolds functional for general applications, exhibiting a very 
good compromise between pores content (over 50 %vol.) and strength (over 4 MPa), were prepared. 
Moreover, scaffolds having a lower porosity degree (over 50 %vol.) and even higher mechanical 
strength (above 5 MPa) were also produced for high strength bone grafting applications. 
Therefore, due to their very good mechanical properties and high bioactivity, CEL2 scaffolds can be 
suggested as effective implants for bone substitutions.  
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Figure legends 
Fig. 1 Polyurethane sponge structure. 
 
 
Fig. 2 CEL2 scaffolds: (a) cubic samples and (b) and prism-shaped samples. 
 
 
Fig. 3 Diffraction patterns of (a) as-poured CEL2 and of CEL2 scaffold obtained after thermal 
treatment at (b) 950 °C or (c) 1000 °C for 3 h. 
 
 
Fig. 4 Micrographs of the sponge impregnated with method A at different magnifications. 
 
 
 
 
Fig. 5 Micrographs of the sponge impregnated with method B at different magnifications. 
 
 
Fig. 6 Micrographs of the sponge impregnated with method C at different magnifications. 
 
 
Fig. 7 Micrographs of CEL2 scaffold prepared with method B: (a) surface and (b) cross-section. 
 
 
 
Fig. 8 Micrographs showing the high pores interconnection of a scaffold obtained with method A. 
 
 
Fig. 9 Well-sintered trabeculae of CEL2 scaffold prepared with method B. 
  
 
 
 
 
 
 
 
Fig. 10 Micrographs of (a) macropores and (b) their well-sintered struts (b) in a scaffold prepared 
with method B-2. 
 
 
 
Fig. 11 Micrographs of the scaffold prepared with method C: (a) macropores with their struts and 
(b) particular of a trabecula. 
 
 
 
 
Fig. 12 (a) Capillarity test performed on CEL2 scaffold and (b) comparison between the cross-
sections of a sample after the test and an as-done scaffold. 
 
 
 
 
Fig. 13 Image analysis results: (a) pores amount and (b) pores area. 
 
 
 
 
 
 
 
 
Fig. 14 Typical compressive CEL2-scaffold stress-strain curve. 
 
 
 
Fig. 15 In vitro tests: (a) HAp agglomerates on scaffold surface after 1 week in SBF and (b) 
corresponding diffraction pattern. 
 
 
 
 
Fig. 16 MG-63 cells on CEL2 scaffold after (a) 10 days and (b) 20 days of culture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tables 
 
Table 1 Preparation methods of CEL2 scaffolds. 
Preparation method 
Cycles of 
infiltration/compression 
Additives Drying Thermal treatment 
A 
Cycle: 1 impregnation followed 
by 3 compressions of 60%; the 
cycle is repeated for 3 times. 
No 
3 h at room 
temperature 
950 °C for 3 h 
A-1 Such as A No 
3 h at room 
temperature + 
80 °C for 2h + 
600 °C for 2 h 
 
950 °C for 3 h 
B 
Cycle: 1 impregnation followed 
by 3 compressions of 60%; the 
cycle is repeated for 3 times and 
then another impregnation is 
carried out with a  compression 
of 33%. 
No 
3 h at room 
temperature 
950 °C for 3 h 
B-1 Such as B 
Ethylene 
glycol 
(10%wt.) 
Such as B 950 °C for 3 h 
B-2 Such as B No Such as B 1000 °C for 3 h 
C 
Cycle: 1 impregnation followed 
by 3 compressions of 60%; the 
cycle is repeated for 3 times and 
then another impregnation is 
carried out without compression. 
No Such as B 1000 °C for 3 h 
 
 
Table 2 Total porosity obtained via density measurements. 
Impregnation method Total porosity (% vol.) 
Method A 68.5 ± 4.6 
Method A-1 72.3 ± 3.3 
Method B 59.4 ± 2.2  
Method B-1 55.8 ± 2.2 
Method B-2 62.1 ± 1.5 
Method C 53.5 ± 3.7 
 
Table 3 Scaffolds volumetric shrinkage. 
Impregnation method Volume shrinkage (%) 
Method A 65.2 ± 4.1 
Method B 65.2 ± 1.3  
Method C 69.9 ± 3.9 
 
Table 4 Compressive strength of the scaffolds (5 samples tested for each preparation method). 
Impregnation method Compressive strength [MPa] 
Method A 1.6 ± 0.5 
Method A-1 1.3 ± 0.4 
Method B 3.9 ± 0.4  
Method B-1 3.8 ± 0.4 
Method B-2 4.7 ± 0.6 
Method C 5.4 ± 1.5 
 
 
